Overview

• The IPO opens for public subscription from June 18 to June 20 with anchor bids on June 17 and shares set to list on the BSE and NSE on June 25.
• The entire ₹499.6 crore offer is a fresh equity issuance with no offer-for-sale component and secured full subscription ahead of the launch.
• Seventy-five percent of the issue is earmarked for qualified institutional buyers, 15% for non-institutional investors and 10% for retail subscribers.
• Proceeds will fund repayment of ₹204.6 crore in borrowings, support ₹177 crore in working capital needs and invest ₹48 crore in subsidiary Buildmex-Infra.
• Backed by PharmEasy founder’s family office, ArisInfra has digitised procurement of over 14 million metric tonnes of construction materials for major developers including The Wadhwa Group, Tata Projects and JSW Cements.